ECSP034795A - "composiciones que contienen imidazotriazinona para administración nasal" - Google Patents
"composiciones que contienen imidazotriazinona para administración nasal"Info
- Publication number
- ECSP034795A ECSP034795A EC2003004795A ECSP034795A ECSP034795A EC SP034795 A ECSP034795 A EC SP034795A EC 2003004795 A EC2003004795 A EC 2003004795A EC SP034795 A ECSP034795 A EC SP034795A EC SP034795 A ECSP034795 A EC SP034795A
- Authority
- EC
- Ecuador
- Prior art keywords
- imidazotriazinone
- compositions containing
- nasal administration
- small amount
- addition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a composiciones que contienen imidazotriazinona para administración nasal que además del inhibidor de PDE de GMPc contienen una pequeña cantidad de anestésico local..
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10118306A DE10118306A1 (de) | 2001-04-12 | 2001-04-12 | Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP034795A true ECSP034795A (es) | 2003-12-01 |
Family
ID=7681379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2003004795A ECSP034795A (es) | 2001-04-12 | 2003-10-08 | "composiciones que contienen imidazotriazinona para administración nasal" |
Country Status (25)
Country | Link |
---|---|
US (2) | US6740306B2 (es) |
EP (1) | EP1381368A2 (es) |
JP (1) | JP2004525968A (es) |
KR (1) | KR20030087072A (es) |
CN (1) | CN1537004A (es) |
AR (1) | AR035821A1 (es) |
BG (1) | BG108245A (es) |
BR (1) | BR0208813A (es) |
CA (1) | CA2443639A1 (es) |
CZ (1) | CZ20032752A3 (es) |
DE (1) | DE10118306A1 (es) |
DO (1) | DOP2002000373A (es) |
EC (1) | ECSP034795A (es) |
EE (1) | EE200300501A (es) |
GT (1) | GT200200070A (es) |
HU (1) | HUP0303877A3 (es) |
IL (1) | IL158255A0 (es) |
MX (1) | MXPA03009314A (es) |
NO (1) | NO20034556L (es) |
PE (1) | PE20021035A1 (es) |
PL (1) | PL363033A1 (es) |
RU (1) | RU2003133143A (es) |
SK (1) | SK12682003A3 (es) |
UY (1) | UY27256A1 (es) |
WO (1) | WO2002083674A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2449163C (en) * | 2001-05-09 | 2010-07-13 | Bayer Healthcare Ag | New use of 2-phenyl-substituted imidazotriazinones |
DE102004023069A1 (de) * | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
AU2005322305B2 (en) * | 2004-12-23 | 2010-09-16 | Roxro Pharma, Inc. | Therapeutic compositions for intranasal administration of ketorolac |
DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
MX2008000087A (es) * | 2005-06-23 | 2008-03-18 | Schering Corp | Formulaciones orales rapidamente absorbentes de inhibidores de la fosfodiesterasa 5. |
AU2006299232A1 (en) * | 2005-09-29 | 2007-04-12 | Bayer Schering Pharma Aktiengesellschaft | PDE inhibitors and combinations thereof for the treatment of urological disorders |
WO2008151734A1 (en) * | 2007-06-13 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of hearing impairment |
TW201002368A (en) * | 2008-06-13 | 2010-01-16 | Roxro Pharma Inc | Unit dose formulations of ketorolac for intranasal administration |
US8277781B2 (en) * | 2009-03-13 | 2012-10-02 | Luitpold Pharmaceuticals, Inc. | Device for intranasal administration |
US8551454B2 (en) * | 2009-03-13 | 2013-10-08 | Luitpold Pharmaceuticals, Inc. | Device for intranasal administration |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
WO2020006606A1 (en) * | 2018-07-05 | 2020-01-09 | Helium 3 Resources Pty Ltd | A pharmaceutical composition and method of use of same |
SE542968C2 (en) * | 2018-10-26 | 2020-09-22 | Lindahl Anders | Treatment of osteoarthritis |
WO2021242913A1 (en) * | 2020-05-26 | 2021-12-02 | Strategic Drug Solutions, Inc. | Formulations and methods for treating erectile dysfunction |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4602099A (en) * | 1973-04-02 | 1986-07-22 | Merrell Dow Pharmaceuticals Inc. | Antirhinovirus agents |
GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9311920D0 (en) | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
GB9514465D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
GB9514473D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
US6018046A (en) | 1996-05-31 | 2000-01-25 | Mochida Pharmaceutical Co., Ltd. | Pyridocarbazole derivatives having cGMP-PDE inhibitory activity |
GB2315673A (en) * | 1996-08-01 | 1998-02-11 | Merck & Co Inc | Treatment of migraine |
WO1998053819A1 (fr) * | 1997-05-29 | 1998-12-03 | Mochida Pharmaceutical Co., Ltd. | Agent therapeutique destine a traiter l'anerection |
AU9214498A (en) | 1997-09-23 | 1999-04-12 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
UA46166C2 (uk) | 1997-11-12 | 2002-05-15 | Баєр Акцієнгезельшафт | 2-фенілзаміщені імідазотриазинони як інгібітори фосфодіестерази, спосіб їх одержання та лікарський засіб на їх основі |
TWI223598B (en) * | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
WO2000000199A1 (en) * | 1998-06-26 | 2000-01-06 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of sildenafil citrate |
CZ20012113A3 (cs) * | 1998-12-14 | 2001-11-14 | Cellegy Pharmaceuticals, Inc. | Prostředky a způsoby pro léčbu onemocnění anorektální oblasti |
-
2001
- 2001-04-12 DE DE10118306A patent/DE10118306A1/de not_active Withdrawn
-
2002
- 2002-04-03 KR KR10-2003-7013280A patent/KR20030087072A/ko not_active Application Discontinuation
- 2002-04-03 WO PCT/EP2002/003663 patent/WO2002083674A2/de not_active Application Discontinuation
- 2002-04-03 RU RU2003133143/15A patent/RU2003133143A/ru not_active Application Discontinuation
- 2002-04-03 SK SK1268-2003A patent/SK12682003A3/sk unknown
- 2002-04-03 EP EP02732548A patent/EP1381368A2/de not_active Withdrawn
- 2002-04-03 CN CNA028114574A patent/CN1537004A/zh active Pending
- 2002-04-03 HU HU0303877A patent/HUP0303877A3/hu unknown
- 2002-04-03 PL PL02363033A patent/PL363033A1/xx not_active Application Discontinuation
- 2002-04-03 BR BR0208813-4A patent/BR0208813A/pt not_active Application Discontinuation
- 2002-04-03 MX MXPA03009314A patent/MXPA03009314A/es unknown
- 2002-04-03 JP JP2002581429A patent/JP2004525968A/ja active Pending
- 2002-04-03 IL IL15825502A patent/IL158255A0/xx unknown
- 2002-04-03 EE EEP200300501A patent/EE200300501A/xx unknown
- 2002-04-03 CA CA002443639A patent/CA2443639A1/en not_active Abandoned
- 2002-04-03 CZ CZ20032752A patent/CZ20032752A3/cs unknown
- 2002-04-04 DO DO2002000373A patent/DOP2002000373A/es unknown
- 2002-04-10 AR ARP020101322A patent/AR035821A1/es not_active Application Discontinuation
- 2002-04-11 US US10/122,694 patent/US6740306B2/en not_active Expired - Fee Related
- 2002-04-11 PE PE2002000303A patent/PE20021035A1/es not_active Application Discontinuation
- 2002-04-11 UY UY27256A patent/UY27256A1/es not_active Application Discontinuation
- 2002-04-11 GT GT200200070A patent/GT200200070A/es unknown
-
2003
- 2003-10-08 EC EC2003004795A patent/ECSP034795A/es unknown
- 2003-10-09 BG BG108245A patent/BG108245A/xx unknown
- 2003-10-10 NO NO20034556A patent/NO20034556L/no not_active Application Discontinuation
-
2004
- 2004-03-30 US US10/813,801 patent/US20040248891A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HUP0303877A2 (hu) | 2004-03-29 |
EP1381368A2 (de) | 2004-01-21 |
JP2004525968A (ja) | 2004-08-26 |
HUP0303877A3 (en) | 2005-05-30 |
IL158255A0 (en) | 2004-05-12 |
DE10118306A1 (de) | 2002-10-17 |
BG108245A (en) | 2005-01-31 |
RU2003133143A (ru) | 2005-04-10 |
US20030022894A1 (en) | 2003-01-30 |
PL363033A1 (en) | 2004-11-15 |
US6740306B2 (en) | 2004-05-25 |
CZ20032752A3 (cs) | 2004-01-14 |
CA2443639A1 (en) | 2002-10-24 |
UY27256A1 (es) | 2002-11-29 |
NO20034556D0 (no) | 2003-10-10 |
WO2002083674A3 (de) | 2003-01-09 |
KR20030087072A (ko) | 2003-11-12 |
WO2002083674A2 (de) | 2002-10-24 |
AR035821A1 (es) | 2004-07-14 |
SK12682003A3 (sk) | 2004-03-02 |
GT200200070A (es) | 2003-01-31 |
EE200300501A (et) | 2003-12-15 |
DOP2002000373A (es) | 2002-11-30 |
NO20034556L (no) | 2003-12-10 |
BR0208813A (pt) | 2004-03-09 |
PE20021035A1 (es) | 2002-11-29 |
MXPA03009314A (es) | 2004-03-10 |
US20040248891A1 (en) | 2004-12-09 |
CN1537004A (zh) | 2004-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP034795A (es) | "composiciones que contienen imidazotriazinona para administración nasal" | |
PA8523201A1 (es) | Nueva composicion farmaceutica | |
ECSP034914A (es) | "azaindoles" | |
HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
SV2004001418A (es) | Formulaciones farmaceuticas de 5,7,14-triazaciclo 10.3.1.0.2,11.04,9) -hexadeca-2(11),3,5,7,9-pentaeno" ref.pc 23248 | |
AP2001002204A0 (en) | Pyrazole derivatives. | |
EA200501268A1 (ru) | Ингибирующие вич 1,2,4-триазины | |
ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
BRPI0412029A (pt) | formulações para microprojeções revestidas contendo contra-ìons não-voláteis | |
ATE469136T1 (de) | Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1 | |
BR0113661A (pt) | Composições farmacêuticas para a liberação tópica de inibidores da enzima ciclooxigenase-2 | |
ECSP045004A (es) | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes | |
HK1076605A1 (en) | Formulations | |
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
CL2009001682A1 (es) | Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00). | |
ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
ECSP066291A (es) | Sistemas emulsionantes que contienen derivados de azetidina | |
UY30356A1 (es) | Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos. | |
CO5580729A2 (es) | Composiciones nutricionales que comprenden cistationina | |
BRPI0408848A (pt) | formulações orais de cladribine | |
HN2001000119A (es) | S-metil-dihidro -ziprasidona para el tratamiento de trastornos psiquiatricos y oculares. | |
HN2002000082A (es) | Composiciones que contienen imidazotriazinona para administracion nasal | |
BR0213463A (pt) | Composições farmacêuticas contendo macrólidos | |
WO2002083108A3 (de) | Zusammensetzungen enthaltend cgmp-pde-inhibitoren und lokalanästhetika zur nasalen applikation | |
PA8556101A1 (es) | 2-amino-6-(fenilo sustituido en las posiciones 2,4,5)-piridinas |